MATTHEW JOHNSON: Open Payments
NPI 1922134592 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,615 in 102 payments from 15 companies in 2025. Trend: 2023 $1,959 · 2024 $2,385 · 2025 $1,615
Food & beverage: $1,615
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 32 | $419 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 13 | $261 |
| Amgen Inc. | 20 | $188 |
| PFIZER INC. | 9 | $155 |
| Regeneron Healthcare Solutions, Inc. | 5 | $122 |
| E.R. Squibb & Sons, L.L.C. | 5 | $85 |
| ABBVIE INC. | 3 | $73 |
| BridgeBio Pharma, Inc. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Alnylam Pharmaceuticals Inc. | 2 | $55 |
Products named: LEQVIO, LifeVest, REPATHA, VYNDAQEL, EVKEEZA, CAMZYOS, Attruby, ONPATTRO.
Industry payments across FL — which companies pay providers there.
